University curriculum vitae format

Doc File 260.50 KByte,



CONDENSED CV

DATE: July 2019

NAME: Larry P. Frohman, M.D.

PRESENT TITLE: Professor of Ophthalmology and Neurosciences

OFFICE ADDRESS: Rutgers, New Jersey Medical School

Institute of Ophthalmology and Visual Science

90 Bergen Street, Suite 6100

Newark, NJ 07103

TELEPHONE NUMBER: (973)-972-2026

E-MAIL ADDRESS: frohman@njms.rutgers.edu

CITIZENSHIP: United States

EDUCATION:

A. Undergraduate Graduate and Professional

Swarthmore College

Swarthmore, PA

B.A. 9/1973 - 5/1976

B. Graduate and Professional

University of Pennsylvania School of Medicine

Philadelphia, PA

M.D. 9/1976 - 5/1980

POSTGRADUATE TRAINING:

A. Internship and Residencies

Presbyterian-University of Pennsylvania Medical Center

51 North 39th Street

Philadelphia, PA

Internship

7/1980 - 6/1981

New York University-Bellevue Medical Center

550 First Avenue

NYC, NY 10016

Residency in Ophthalmology

1981-1984

B. Research Fellowships

New York University-Bellevue Medical Center

550 First Avenue

NYC, NY 10016

Fellowship in Neuro-ophthalmology

1984-1985

MILITARY:

None

ACADEMIC APPOINTMENTS:

New York University Medical Center

Department of Ophthalmology

Clinical Teaching Assistant

1984-1985

Rutgers, - New Jersey Medical School (Formerly UMDNJ)

Department of Ophthalmology

▪ Instructor in Ophthalmology

1985-1986

▪ Assistant Professor of Ophthalmology and Director of Neuro-ophthalmology

1986-1991

▪ Associate Professor of Ophthalmology with tenure & Director of Neuro-ophthalmology

1991-2006

▪ Professor of Ophthalmology with tenure and Director of Neuro-ophthalmology

2006-present

▪ Vice Chair of Ophthalmology

1991-present

▪ Associate Professor of Neurology & Neurosciences

1993-2006

▪ Professor of Neurology & Neurosciences

2006-present

▪ Acting Chair of Ophthalmology

6/1993-1/1994

▪ Associate Director of Clinical Affairs, UMDNJ-New Jersey School

1996-1998

▪ Director of Practice Development and Clinical Productivity

2011-2013, UMDNJ-New Jersey School

HOSPITAL APPOINTMENTS:

New York University Medical Center

Department of Ophthalmology

Fellow/Attending

1984-1985

United Hospitals Medical Center

Department of Ophthalmology

Attending

1985-1997

Beth Israel Medical Center

Department of Ophthalmology

Ophthalmology Consultant

1985-1988

University Hospital (UMDNJ-NJMS)

Department of Ophthalmology

Attending in Ophthalmology

1985-present

East Orange Veteran's Administration Medical Center

Department of Ophthalmology

Attending in Ophthalmology

1985-1994,

Consultant

1995-present

St. Barnabas Medical Center, Livingston

Department of Ophthalmology

Ophthalmology Consultant

1985-present

Columbus Hospital

Department of Ophthalmology

Ophthalmology Consultant

1997-2002

Overlook Hospital

Department of Ophthalmology

Ophthalmology Consultant

1998-2008

OTHER EMPLOYMENT OR MAJOR VISITING APPOINTMENTS:

None

PRIVATE PRACTICE

The Eye Institute of New Jersey

15 South Ninth Street

Newark, NJ 07107

1985-1992

Institute of Ophthalmology and Visual Science

Doctors Office Center

Rutgers, New Jersey Medical School

University Ophthalmology Associates

90 Bergen Street, Suite 6100

Newark, NJ 07101-1709

1992-present

P: (973) 972-2065

University Ophthalmology Associates

556 Eagle Rock Avenue

Roseland, NJ 07068

1995-present

P: (973) 972-2108

My private practice in neuro-ophthalmology is through the Institute of Ophthalmology & Visual Science, Rutgers –NJMS (formerly UMDNJ), entirely through auspices of NJMS-Faculty Practice (UPA), 1985-present. Our satellite office is located in Roseland, NJ. It is a referral-based practice serving several states.

LICENSURE:

▪ New Jersey

25M********

1985- Exp. 06/30/2019

▪ New York

146726-1

1981-2004

(opted for allowed inactive status after 2003)

DRUG LICENSURE:

▪ NJ CDS

D04******

1985- Exp. 10/31/2017

▪ DEA

AF*******

1982- Exp. 09/30/2018

CERTIFICATION:

American Board of Ophthalmology

1985 (permanent)

MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:

Sigma Xi

Member

1975-present

American Medical Association

Member

1977-present

American Academy of Ophthalmology

▪ Member

1982-present

▪ Member

Self Assessment Committee

1995-2002

▪ Chair

Multimedia Education Subcommittee

1996-2002

▪ Media Spokesperson- Neuro-ophthalmology

2000-2016

▪ Chair

Clinical Knowledge Panel, Section on Neuro-ophthalmology/Orbit

2002-2009

▪ Northeast Regional Chair Council

2004

▪ Member

Council Section Nominating Committee

2006

▪ Deputy Section Leader, Council

2007

The Association for Research in Vision and Ophthalmology (ARVO)

Member

1988-present

The Advisory Board Company

Member, Medical Leadership Council

1996-1997

North American Neuro-Ophthalmology Society

▪ Member

1989-present

▪ Member, Board of Trustees

1996-present

▪ Vice President

1996-2000

▪ President Elect

2002-2004

▪ President

2004-2006

▪ Chair, Board or Trustees

2006-2008

▪ Treasurer

2008-2012

▪ Executive Vice President

2011-present

▪ Chair, Managed Care Committee

1993-2000

▪ Member, Bylaws Committee

1996

▪ Chair, Long Range Planning Committee

2000-2001

▪ Member, Education Committee

2000-2008

▪ Chair, Education Committee

2002-2004

▪ Associate Councilor

2002

▪ Councilor

2003-2008

▪ Chair, Nominating Committee

2006-2010

▪ Member, Nominating Committee2006-

▪ Member, NANOS ICD-11 Taskforce

2010-present

▪ Member, Long Range Planning Committee

2011-2

▪ Chair, Social/Meeting Committee

2014-

▪ Chair, Strategic Planning Committee

2014-

▪ American Academy of Neurology

Member, 2016-2017

HONORS AND AWARDS:

Tomorrow's Scientists and Engineer's Award

1973

Hannah Leedom Post-Graduate Fellowship

University of Pennsylvania School of Medicine

1976-1980

Hunter Grubb Post-Graduate Fellowship

University of Pennsylvania School of Medicine

1976-1980

Resident Education Award

NJMS Department of Ophthalmology

1987

Teaching and Service Award

New Jersey Medical School

1988; 1991

Session Organizer and Moderator

North American Neuro-ophthalmology Society

2/1991, Park City, Utah

Session Moderator

Frank Walsh Neuro-ophthalmology Society

Mar 13-14, 1993, New York, NY

Session Organizer & Moderator

North American Neuro-ophthalmology Society

March, 1994,

Best Doctors in America

Woodward White Press (published bi-annually

1994-present

Honor Award

American Academy of Ophthalmology

1995

The Best Doctors in America

American Health Magazine[1]

1996

Excellence in Education Award

American Association of Association Executives to American Academy of Ophthalmology (AAO) for Provision CD-ROM concept developed by Drs. Frohman and Wisnicki for AAO

1998

Co-Chair, Neuro-ophthalmology Symposium/Free Paper Session

American Academy of Ophthalmology

1998 New Orleans, LA

Platform reviewer:“Pattern Visual Evoked Potential in the Diagnosis of Functional Visual Loss”,

American Academy of Ophthalmology

1999 Orlando, October

How to Find the Best Doctors New York Metro Area

Castle Connolly Medical Press

1998-2001

Platform reviewer for “Chiari I Malformation Mimicking Pseudotumor Cerebri: neuroimaging and Treatment”

American Academy of Ophthalmology,

2000 Dallas, October

Who's Who in America

Marquis

2000-present

Best Doctors in the Northeast

Woodward White Press

1997

Best Doctors in New Jersey

New Jersey Magazine

1998, 2007

Best Doctors in New York Area

New York Magazine

1999, 2000, 2001, 2005-2012

Who's Who in Medicine and Healthcare

2002-2003 edition

Secretariat Award (first year given) for special contributions to education in ophthalmology

American Academy of Ophthalmology

2002; 2004

Senior Achievement Award

American Academy of Ophthalmology,

2003

Selected as program Co-Chair, Vascular Disease in Neuro-ophthalmology

NANOS Section at American Academy of Ophthalmology

2004, New Orleans

Who's Who in the World

Marquis

2005

Best Doctors in America

database

2005-

Top Doctor

New Jersey Monthly Magazine

2007

Top Doctor: New York Metro Area

Castle Connolly Medical Ltd

2001-present

Guide to America’s Top Ophthalmologists

Consumer Research Council of America

database

2008, 2013

Resident Education Award

The Institute of Ophthalmology & Visual Science

2009, Newark, NJ,

Winner, Distinguished Service Award

North American Neuro-ophthalmology Society

2010

Session Moderator, Neuro-ophthalmology of Cancer

North American Neuro-ophthalmology Society Annual Meeting

March 10, 2010, Tucson, AZ,

Top Doctor, Inside Jersey Magazine

Castle Connolly Medical Ltd.

2009-present

Patients’ Choice Physician

Consumer Research, MDx Medical, Inc.,

2011

Faculty of the Year

NJMS

2012

Top Ophthalmologists

U.S. News & World Report

2012

Hoyt Lecturer

American Academy of Ophthalmology

2016

America's Most Honored Professionals- Top 1%

American Registry

2016-present

Top Doctor NY Metro Awarded

Castle Connolly Medical Press

2017 – 2018

Top Doctor NY Metro Awarded

Castle Connolly Medical Press

2018 – 2019

Top Doctor, Inside Jersey Magazine

Castle Connolly Medical Ltd.

2018

BOARDS OF DIRECTORS/TRUSTEES POSITIONS:

Board of Directors, North American Neuro-ophthalmology Society

Member

1996-present

Faculty Practice of New Jersey Medical School

▪ Member, Board of Directors

1985-present

▪ Vice President

1988-1991

▪ President

1992-1995, 2001-2010

▪ Secretary

1996

▪ Vice President

1997-2000, 2011 - present

Medical Advisory Board, Garden State Myasthenia Foundation

Member

1988-present

Doctor's Center Management Corporation

Vice President

1992-2010

President 2011

Board of Governors, New Jersey Academy of Ophthalmology

Member

1994-1996

Board of Trustees, Eye Institute of New Jersey

Member

1993-2012

New Jersey Medical School Physicians Corporation

Founding Executor

1994-1995

University Health Partnership-New Jersey Medical School Physicians Corporation, (NJMED)

▪ Board Member

1994-2005

▪ Vice President for Reimbursement and Board Vice Chair

1995-7/1/98, 11/01-9/03

▪ Officer at Large

12/98-11/01

SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES:

None

SERVICE ON MAJOR COMMITTEES:

A. International

North American Neuro-ophthalmology Society[2]

1. Educational Slide Committee

Chair

1991-1997

2. Practice Management Committee

• Member

1991

• Co-Chair

1993

• Chair

1994-2000

3. Organizing Committee, Frank Walsh Society,

Member

1993

4. Nominating Committee

Member

1999, 2005, 2010 (present)

5. Web-based Education Subcommittee

Member

2000-2008

6. Long Range Planning Committee

Chair

2000-2002

7. Education Committee

• Member

2000

• Chair

2002-2004

8. Scientific Program Subcommittee

• Member

2002

• Chair

2002-2004

9. NANOS ICD-11 Taskforce

Member

2010-present

10. Finance Committee Chair 2008-2012

B. National

American Academy of Ophthalmology

▪ Managed Care Advocacy Committee

Member,

1994-1996

▪ Continuing Education/Self Assessment Committee

Member,

1995-2002

▪ Subcommittee on Multimedia Continuing Education Products

Chair

1996-2002

▪ Electronic Compendium of Ophthalmic Knowledge Steering Committee

Member

1999-2000

▪ Clinical Education Planning Group

Member

1999-2001

▪ Associate Councilor

2002-2003

▪ Clinical Knowledge Panel in Neuro-ophthalmology

Chair

2002-2009

▪ Media Advisory Task Force

Member

2002 – 2016

▪ Councilor

2003-2008

▪ Northeast Regional Chair

Council

2004

▪ Council Task Force on the Subspecialty Certification

Member

2004-2008

▪ Deputy Chief of Council

C. Editorial Boards

Systemic Diseases, Journal of Neuro-ophthalmology

Section Editor

1996-2001

American Academy of Ophthalmology EyeNet Magazine

Member, Editorial Advisory Board

2002-2008

D. AdHoc Reviewer

Neuro-ophthalmology

Journal of Allergy and Clinical Immunology

Journal of Neuro-ophthalmology

Archives of Ophthalmology

Ophthalmology

American Journal of Ophthalmology

Survey of Ophthalmology

British Journal of Ophthalmology

Brain

Journal of Ocular Immunology and Inflammation

Eye,

E. University Physicians Associate

Faculty Practice Board (UPA)

▪ Member

1985-present

▪ Vice President

1988-1991

▪ President

1992-1995, 2001-2010

▪ Secretary

1996

▪ Vice President

1997-2000, 2011

TEACHING RESPONSIBILITIES:

A. Lectures or Course Directorships

Rutgers, New Jersey Medical School (formerly UMDNJ)

1. Ophthalmology training program

Neuro-ophthalmology

12h/yr (lecture), 5h/yr (conference)

B. Instruction

Rutgers, New Jersey Medical School (formerly UMDNJ)

1. Ophthalmology training program

Tutorial in neuro-ophthalmology

1986-1994

40h/yr

American Academy of Ophthalmology

1. Multi-media based education

1996-2002

2. Clinical Knowledge Panel, Section on Neuro-ophthalmology/Orbit

Curriculum, American Board of Ophthalmology recertification

Chair

2002- 2008

3. Knowledge Base Curriculum

Neuro-ophthalmology/Orbit Section recertification

2006

North American Neuro-ophthalmology Society

Education Committee

Society CME; Annual meeting content

Chair

2002-2004

MAJOR RESEARCH INTERESTS

My overall interest is in unexplained visual loss/symptomatology caused by undetected or unknown systemic disease, such as vasculitis, autoimmune diseases, and sarcoidosis. We have published papers on diagnosing autoimmune optic neuropathy, on how to detect occult sarcoidosis presenting as neuro-ophthalmic disease, and on neuro-ophthalmic signs of vasculitis. I have also published on treatment strategies for these entities, including the first use of thalidomide for neurosarcoid (Celgene- Federal Drug Administration, Compassionate Use of Thalidomide for Neurosarcoid, 1998, IND 55,321).

The other area of interest has been educational techniques in ophthalmology. I have, with Dr. Jay Wisnicki, developed the patient simulation paradigm that was used in the American Academy of Ophthalmology’s ProVision interactive CD series, as well as chaired their development of web-based simulations. I am one of three grantees on the NOVEL (Neuro-ophthalmology Virtual Education Library) project funded by the National Library of Medicine. In this project, we are linking educational assets (videos, audio lectures, still images, PowerPoint lectures...) to a core curriculum that we have developed at the North American Neuro-ophthalmology Society (NANOS).

CLINICAL RESPONSIBILITIES:

GRANT SUPPORT:

A. Principal Investigator

1. Dean’s Biomedical Research Support Program

Personal Proteomics as an Aid in the Diagnosis of Unknown Optic Neuropathies

7/1/2016-6/30/2017

$3,000

2. Quark Pharmacueticals $20,997.60 per subject, PI for NJ site

A Phase 2/3, Randomized, Double-Masked, Sham-controlled Trial of QP-1007 Delivered by Single or Multi-Dose Intravitreal Injection(s) to Subjects with Acute Non-Arteritic Ischemic Optic Neuropathy (NAION).

3. Neuro-ophthalmology Research Disease Investigators’ Consortium (NORDIC),

Idiopathic Intracranial Hypertension Treatment Trial

NEI through NORDIC, 2010-2015

$9,629 per patient plus start up costs

4. North American Neuro-ophthalmology Society

Neuro-ophthalmology Virtual Education Library (NOVEL)

Pfizer, Inc., 01/01/2008-12/31/2008

direct costs = $80,000, total = $80,000

5. University of Medicine and Dentistry of New Jersey

Patient Simulations in Ophthalmology for Medical Students and Primary Care Physicians

UMDNJ Educational Technology Grant, 2004

direct costs = $15,000, total = $15,000

6. Haag-Streit Diagnostics

Establishment of normal values on automated kinetic perimetry in children

Haag -Streit, 2003

direct costs = $8,644, total = $8,644

7. Fund for the New Jersey Blind

Portable Computerized Video Device to allow those with hemifield defects to see their blind hemifield, 12/10/2001

direct costs = $5,000, total = $5,000

8. Fight for Sight, Inc

Raynaud’s Disease as a Risk Factor for Non-Arteritic Ischemic Optic Neuropathy

09/2001-08/2002

direct costs = $20,000, total = $20,000

9. Eye Institute of New Jersey

Use of Retrospective Chart Review to Determine the Proper Therapies of Two Unusual Subsets of Two Common Neuro-ophthalmic Conditions: Pseudotumor Cerebri in Pregnancy and Traumatic Optic Neuropathy in the Comatose Patient

2001

direct costs = $15,000, total = $15,000.

10. Allergan

Study of a Topical Agent for Ischemic Optic Neuropathy

2000

(multicentered trial, approximately $82,000 at NJMS- study halted in recruitment).

11. The Goldring Family Foundation

2000, unrestricted

direct costs = $2,500, total = $2,500

12. Fund for the New Jersey Blind

Autoantibodies in Optic Neuritis. (Co-Principal Investigator),

7/1990-06/1991

direct costs = $10,243, total = $10,243

13. Lions Eye Research Foundation of NJ

Optic Nerve Autoantibodies Optic Nerve,

7/1/1990-6/30/1991

direct costs = $16,000, total = $16,000

14. Eye Institute of New Jersey

post-doctoral support for Dr. Z. Dong, Immuno-Ophthalmology Center

(Co-Principal Investigator) 1990-1991

$13,000.

15. National Society to Prevent Blindness - Fight for Sight, Inc

Autoantibodies in OpticNeuritis

7/1990-9/1992

direct costs = $12,000, total = $12,000

16. Sandoz Pharmaceuticals- Educational

Symposium on Immunologic Disease of the Eye

(Co-Principal Investigator), 5/1989

direct costs = $25,000, total = $25,000

17. Lions Sight Foundation

Optic Neuritis and Auto Antibodies

(Co-Principal Investigator) 1/1988-12/1988

direct costs = $3,500, total = $3,500.

18. Fund for the New Jersey Blind

A New Optical Device for the Evaluation of Optic Neuropathies

1/1987-12/1987

direct costs = $12,000, total = $12,000.

19. Foundation of UMDNJ

1/1986-12/1986

direct costs = $15,340, total = $15,340

B. Co-Investigator

1. UMDNJ-NJMS Department of Neurology

Acetelion MS Study AC58B201 NORDIC. S. Kamin (P.I.)

direct costs = $64,015 , total = $80,907

2. UMDNJ Educational Technology Grant

Web-based Ocular Imaging Library and Credentialing Program for Improvement of Ophthalmology Education. Suqin Guo (P.I.)

2004

direct costs = $15,000, total = $15,000

3. University of Utah

National Library of Medicine, Neuro-ophthalmology Virtual Education Library (NOVEL). N. Lombardo (P.I.)

2003-2006

direct costs = $433,739, total = $433,739

4. CHAMPS Study

Biogen, A Randomized Double-Blind, Placebo-Controlled Study of Avonex (Interferon Beta-1a) in the Treatment of Subjects at High Risk for Development of Multiple Sclerosis Following the First Onset of an Isolated Demyelinating Event. Stuart Cook (P.I.)

1996

direct costs = 19,897, total = $24,872

5. Foundation of UMDNJ

Immunologic Analysis of Tears in Corneal Transplants, L. Bielory (P.I.)

1/1991-12/1991

direct costs = $21,087, total = $21,087

6. Lions Eye Research Foundation of New Jersey

Immunological Analysis of Tears. L. Bielory ( P.I.)

10/1990-09/1991

direct costs = $22,135, total = $22,135

7. Sandoz Pharmaceuticals, Educational Grant

Symposium on Uses of Cyclosporine. L. Bielory (P.I.)

01/1991-11/1991

direct costs = $13,500, total = $13,500

8. Fund for the New Jersey Blind

Immunology of Tears. L. Bielory (P.I.)

1/1989-12/1989,

direct costs = $4,133, total = $4,133

9. Fund for the New Jersey Blind

Autoantibodies in Optic Neuritis. L. Bielory (P.I.)

1/1988-12/1988

direct costs = $2,239, total = $2,239

10. Fight for Sight, Inc

PD#022-88, L. Bielory-P.I

7/01/1988-06/30/1989

direct costs = $12,000, total = $12,000

11. Fund for the New Jersey Blind

Use of a Variable Neutral Density Filter for the Evaluation of Afferent Pupillary Defects in Amblyopia. R. Wagner, P.I

1/1987-12/1987

direct costs = $5,750, total = $5,750

C. Pending

1. None

D. Sponsor

1. UMDNJ-New Jersey Medical School

Pan, Lawrence, MS-2

Summer Student Program, Does Lacrimal Gland Size Matter in Differentiating Sarcoid versus Typical Optic Neuritis

2004

2. UMDNJ-New Jersey Medical School

Wilkerson, Mark, MS-2

National Academy of Science-Sigma Xi, Immunology of Tears

6/1991-9/1991

$1,087

3. UMDNJ-New Jersey Medical School

Fucigna, Robert, MS-4

Sigma Xi, Immunologic Tear Assays

6/90-9/90

$850

4. UMDNJ-New Jersey Medical School

Fucigna, Robert, MS-

Fight for Sight, Immunologic Tear Assays

6/90-9/90

$1,000.

5. UMDNJ-New Jersey Medical School

Lucca, John, MS-

Sigma Xi, Keratoconjunctivitis Sicca in Human Immunodeficiency Virus Infections

6/1989-12/1989

$1,000

6. Albert Einstein College of Medicine

Cohen, Avi, MS-4

Sigma Xi, Optic Neuritis and Autoantibodies

6/1989-9/1989

$900

PUBLICATIONS:

A. Refereed Original Article in Journal

| |

| |

1. Xia T, Huz J, Frohman LP, Turbin RE, Bhagat N. Optic Neuropathy after Repair of Rhegmatogenous Retinal Detachment" #EYE-18-1034, Eye. 33(3):514-515, 2019 03.

2. Frohman, LP., Budoff G, Bhagat N. Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting with Dense Premacular Hemorrhage. AAO Journal of Ophthalmology. July 2019

3. Rafailov, L, Langer, P, Frohman, LP, and Turbin, RE. The Clinical and Magnetic Resonance Imaging Characteristics of Post-Fenestration Optic Nerve Sheath Pseudomeningoceles. Ophthalmic Plastic and Reconstructive Surgery,. Ophthalmic Plastic & Reconstructive Surgery. 35(2):159-164, 2019 Mar/Apr.

4. Subramanian PS. Frohman LP. Biousse V; et al. Impact of the Elimination of Consultation Codes on Neuro-Ophthalmology in the United States. J Neuro-Ophth. 38(1):4-6, March 2018.

5. Frohman LP. A Profile of Neuro-Ophthalmic Practice Around the World. J Neuro-Ophth. 38(1):47-51, March 2018.

6. Wong, SH, Turbin RE, Frohman, LP. Takayasu arteritis-related photic and postprandial amaurosis. Digital J. of Ophthalmol. 23(4):13-14, Oct. 2017

7. Frohman, LP. Neuro-Ophthalmology: Transitioning From Old to New Models of Health Care Delivery. J Neuro-Ophth.37(2):206-209 June 2017.

8. Liu JK, Gandhi C, Inder S, Frohman LP, Amuluru K. Reversal of Visual Impairment Associated with Vasospasm After Resection of Sphenoclinoidocavernous Meningioma with Intra-arterial Verapamil. WORLD NEUROSURGERY. August 2016Volume 92, Pages 581.e1–581.e5 Accepted for Publication.

9. Frohman L, Wong AB, Matheos K, Leon-Alvarado LG, Danesh-Meyer HV. New Developments in Giant Cell Arteritis. Survey of Ophthalmology. Survey of Ophthalmology. 61(4):400-21, 2016.

10. Khodarahmi I, Ghesani N, Turbin RE, Frohman LP. ¹⁸F-fluorodeoxyglucose Uptake in Neurosarcoid Dural Plaque on PET/CT. Clinical Nuclear Medicine. 41(9):e410-1, 2016 Sep.

11. Wong S, Turbin RE, Frohman LP. Treatment of Takayasu Arteritis-related Photic and Postprandial Amaurosis. European Journal of Ophthalmology. Accepted for publication.

12. Malihi M, Frohman LP, Turbin RE. Is Saturday Retinopathy Being Reported More Frequently? JAMA Ophthalmology. 134(2):238, 2016.

13. Nayak NV, Frohman LP, Lambert WC, Langer PD. Post irradiation periocular granuloma faciale associated with uveitis. Ophthal Plast Reconstr Surg. 2014 Jul-Aug;30(4):e92-5. doi: 10.1097/IOP.0b013e3182a22b03.

14. Malihi M, Turbin R, Frohman L Saturday Night Retinopathy with Ophthalmoplegia: A Case Series. Neuro-ophthalmology, 2015 Feb; doi:10.3109/01658107.2014.997889

15. Frohman L. Therapy of Neuro-Ophthalmic Sarcoidosis. J. Neuro-ophthalmology, 35(1):65-72, 2015

16. Simon, MA, Duffis EJ , Curi, MA, Turbin, RE, Prestigiacomo CJ, and Frohman LP. Papilledema due to a permanent catheter for renal dialysis and an arteriovenous fistula: A "two hit" hypothesis. J Neuro-ophthalmology, 2014 Mar; 34:29-33.

17. Pinney EL, Ferreyra HA, Frohman L. Surv Ophthalmol. A curious case of glaucoma? Surv Ophthalmol. 2014 Mar-Apr; 59(2):245-50.

18. Nayak NV, Frohman LP, Lambert WC, Langer PD. Postirradiation Periocular Granuloma Faciale Associated With Uveitis. Ophthal Plast Reconstr Surg. 2013 Nov 5. [Epub ahead of print]

19. Kalyoussef E, Offor N, Quraishi H, Turbin, R, and Frohman LP. Idiopathic Intracranial Hypertension in a Child with Obstructive Sleep Apnea Cured by Tonsillectomy/Adenoidectomy. J. Neuro-ophthalmology, 2013 Dec;33(4):413-4.

20. Tannen BL, Kolomeyer AM, Turbin RE, Frohman L, Langer PD, Oh C, Ghesani NV, Zuckier LS, Chu DS. Lacrimal Gland Uptake of 67Ga-Gallium Citrate Correlates with Biopsy Results in Patients with Suspected Sarcoidosis. Ocul Immunol Inflamm 06/2013; DOI:10.3109/09273948.2013.791700

21. Chaudry A, Tekchand R, Frohman LP, Liu JK, Eloy A. Miller Fisher variant on Guillain-barre syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome. Laryngoscope 2012 May; 122(5):970-2.

22. Pelegrin L. Mesquida M. Rey A. Sanchez-Dalmau B. Frohman LP. Clinical challenge: The blind runner (Takayasu’s arteritis). Surv Ophthalmol 2012Sep; 57(5):486-94

23. Frohman L, Digre K. Elimination of consult codes in neuro-ophthalmology: another blow to our subspecialty? J Neuroophthalmol 2010; 30(2):210-1.

24. Elmalen VI, Younge BR, Biousse V, Leavitt JA, Moster ML, Warner J, Kupersmith MJ, Landau K, Brodsky MC, Frohman LP, May ER Tomsak RL, Newman NJ "Clinical Course and Prognosis of Trochlear Nerve Schwannomas." Ophthalmology 2009 116(10):2011-6.

25. Frohman LP, Della Torre K, Turbin R, Bielory L. Clinical characteristics, diagnostic criteria, and therapeutic outcomes in autoimmune optic neuropathy. Br J Ophthalmol 93.12 (2009): 1660-666

26. Digre K, Lombardo N, Frohman LP, Friedman D. Upgrades in the neuro-ophthalmology virtual education library (NOVEL). J Neuro-Ophthalmol 2008; 28(3):253-4.

27. Frohman LP. The human resource crisis in Neuro-ophthalmology. J Neuro-Ophthalmol 2008; 28(3):231-4.

28. Tannen BL, Ghesani N, Frohman LP, Eichler J, Maldjian P, Chu DS. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis. Ocular Immunol Inflamm 2008; 16(1-2):25-7.

29. Zamecki KJ, Frohman LP, Turbin RE. Severe visual loss associated with idiopathic intracranial hypertension (IIH) in pregnancy. Clin Ophthalmol 2007; 1(2): 99-103.

30. Digre KB, Lombardo NT, Frohman LP. The neuro-ophthalmology virtual education library (NOVEL). Neuro-Ophthalmol 2007; 31:175-8.

31. Hosler MR, Turbin RE, Cho ES, Wolansky LJ, Frohman LP. Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma. J Neuro-Ophthalmol 2007; 27(2): 95-8.

32. Turbin RE, Maxwell DN, Langer PD, Frohman LP, Hubbi B, Wolansky L, Mori M. Patterns of transorbital intracranial injury: a review and comparison of occult and non-occult cases. Surv Ophthalmol 2006; 51(5):449-60.

33. Shinder R, Frohman LP, Turbin RE. Regression of bilateral optic disc edema after discontinuation of amiodarone. J Neuro-ophthalmol 2006; 26(3):192-4.

34. Turbin RE, Wladis EJ, Frohman LP, Langer PD, Kennerdell JS. A role for surgery as adjuvant therapy in optic nerve sheath meningioma. Ophthal Plast Reconstr Surg 2006; 22(4):278-82.

35. Chung JH, Van Stavern GP, Frohman L, Turbin RE. Adalimumab-associated optic neuritis. J Neurologic Sci 2006; 244:133-6.

36. Mathews M, Savino P, Lee H-J, Frohman L, Sergott R. Spinal fluid leak after chiropractic manipulation of the spine. Arch Ophthalmol 2006; 124:283.

37. Frohman L. The approach to bilateral simultaneous isolated optic neuritis. [Editorial] Br J Ophthalmol 2006; 90(5):526-7.

38. Cuadra S, Padberg F, Turbin RE, Farkas J, and Frohman, LP. Cerebral venous hypertension and blindness: A reversible complication. J Vasc Surg 2005; 42(4):792-5.

39. Frohman LP. How Can We Assure That Neuro-ophthalmology Will Survive? (Editorial) Ophthalmol 2005; 112(5):741-50.

40. Behbehani R,Sergott RC, Frohman LP. Foggy Vision (Clinical Challenge)[3] Surv Ophthalmol 2005; 50(3):231-96.

41. Lee H, Jilani M, Frohman L, Baker S. CT of Orbital Trauma. Emergency Radiology 10:168-172, 2004

42. Digre K and Frohman L. Neuro-ophthalmology Virtual Library (NOVEL) J Neuro-ophthalmol 2004; 24:91

43. Frohman L, Digre K. Ophthalmic subspecialty fellowship accreditation and ophthalmic subspecialty certification: still hot issues. J Neuro-ophthalmol 2004; 24:94

44. Cohen A, Kishore K, Wolansky L, and Frohman LP. Pituitary apoplexy occurring during large volume liposuction surgery. J Neuro-ophthalmol 24:31-33, 2004.

45. Schickner DC, Yarkoni A, Langer P, Frohman L, Chen X, Folberg R, and Del Priore LV. Panophthalmitis due to Clostridium septicum. Am J Ophthalmol 137(5) 942-944, 2004.

46. Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 2003 Sep;23(3):190-7.

47. Frohman L, Turbin R, Bielory L, Wolansky L, Lambert WC, Cook S. Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child. Am J Ophthalmol 2003 Aug;136(2):358-60.

48. Turbin RE, Khoobiar SA, Langer P, Amesur K, Frohman LP, Warren F, Baredes S, Kennerdell JS. Adjuvant Therapy for Invasive Sino-orbital Fungal Infection Conjunctiva. J Neuroophthalmol 2002 June; 22(2):178-9.

49. Vaphiades MS, Eggenberger ER, Miller NR, Frohman L, Krisht A. Resolution of Papilledema after Neurosurgical Decompression for Primary Chiari I malformation. Am J Ophthalmol 2002; 133:673-678.

50. Dinowitz M, Leen JS, Hameed M, Wolansky L, Frohman L. Sudden painless visual loss in an adult. Surv Ophthalmol 46(2):143-8, 2001 Sep-Oct.

51. Frohman L, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuro-ophthalmol 21:132-137, 2001.

52. Frohman L. Systemic Disease and Neuro-Ophthalmology: Annual Update 2000 (Part II) J Neuro-ophthalmol 12:74-82, 2001

53. Frohman, LP, Grigorian R, Slamovits T. Evolution of Sarcoid Granulomas of the Retina. Am J Ophthalmol 131:661-2, 2001.

54. Frohman L, Frieman B, Wolansky L. Reversible blindness due to optic chiasmitis secondary to systemic lupus erythematosus. J Neuro-ophthalmol 21:18-21, 2001

55. Frohman, LP. Discussion of Xu Shizhao, Meyer David, Matthews Dennis, and Yoser Seth. “Pattern Evoked Potential in the Diagnosis of Functional Visual Loss.” Ophthalmol 108; 2001:80-82

56. Frohman L. Lama P. Annual update of systemic disease--1999: emerging and re-emerging infections (Part II). J Neuro-ophthalmol 20(1):48-58, 2000.

57. Frohman LP, Burg S. Interactive Ophthalmic Education: Learning for the Future. Ophthalmology Clinics of North America 13:279-287, 2000.

58. Frohman LP and Lama P. Annual Update of Systemic Disease--1999: Emerging and Re-emerging Infections (Part I). J Neuro-ophthalmol 19(4):263-73, 1999.

59. Frohman LP and Bielory L. Not So Slowly progressive Visual Loss (Syphilitic Optic Neuropathy- Clinical Challenge Discussion) Surv Ophthalmol 1999:44(3) 247-252

60. Bennett JL, Galetta SL, Frohman LP, Mourelatos SD, Gultekin SH, Dalmau JO, and Posner, JB. Neuro-ophthalmic Manifestations of a Paraneoplastic Syndrome and Testicular Carcinoma. Neurology 1999:52:864-867

61. Lama Paul and Frohman Larry. Systemic Diseases-Annual Review, 1997. J Neuro-ophthalmol 1998:18:127-142.

62. Frohman Larry and Lama Paul. Systemic Diseases-Annual Review, 1996. J Neuro-ophthalmol 1998:18:67-79.

63. Kupersmith Mark J, Frohman Larry, Sanderson Matthew, Jacobs Jennifer, Hirschfield James, Ku Christie, and Warren Floyd. Aspirin Reduces the Incidence of Second Eye NAION: A Retrospective Study. J Neuro-Ophthalmol 1997:17:250-253.

64. Frohman, Larry, Wolanski, Leo. Magnetic Resonance Imaging of Syphilitic Optic Neuritis/ Perineuritis. J Neuro-ophthalmol 1997:17:57-9

65. Barchuk William T, Centeno Ligaya, Frohman Larry, and Bielory William. Immunology and Ocular Manifestations of Giant cell Arteritis. Ocular Immunology and Inflammation, 1997; 5:141-145.

66. Wolansky LJ, Shaderowfsky PD, Sander R, Frohman LP, Kalnin AJ, Lee HJ. Optic Chiasmal Compression by Venous Aneurysm: Magnetic Resonance Imaging Diagnosis. J Neuroimaging 1997; 7:46-7.

67. Wolansky Leo J, Rao Satyaveni B, Schulder Michael, Elias Brad, Brautigan Rob, Choudri Ajay, Kalnin, Andrew J, Frohman, Larry P, and Lee Huey-Jen. Extrasellar Extension of Pituitary Lesions. Comparison of T2-Weighted Fast Spin Echo MRI with T1-Weighted Sequences. Intl J Neuroradiology 1996; 2:147-152.

68. Galati Lisa, Baredes Soly, Mauriello Joseph, and Frohman Larry. Visual Loss Reversed after Treatment of Acute Bacterial Sinusitis. Laryngoscope 1996;106:148-151.

69. Bielory Leonard and Frohman Larry. UMDNJ and Managed Care. New Jersey Medicine. 1995;92:651-654.

70. Vargas, Marino, Kupersmith, Mark, Savino, Peter, Petito, Frank, Frohman, Larry, and Warren, Floyd. Homonymous Field Defect as the First Manifestation of Creutzfeldt-Jakob Disease. Am J Ophthalmol 1995; 497-504.

71. Mauriello JA, Shaderofsky P, Gizzi M, Frohman L. Management of Visual Loss after Optic Nerve Sheath Decompression in Patients with Pseudotumor Cerebri. Ophthalmol 1995; 102:441-445

72. Frohman, Larry, Warren, Floyd. Myasthenia Gravis by Another Name:An Elusive Imposter (Clinical Challenge) Surv Ophthalmol 38:219-226, 1993[4].

73. Bielory L, Kupersmith MJ, Warren F, Bystryn JC, and Frohman LP. Skin Biopsies in the Evaluation of Atypical Optic Neuropathies. Ocular Immunology and Inflammation, 1:231-241, 1993[5].

74. Haupt E, Katz R, Chin P, Cinotti, AA, and Frohman L. Distinct Patterns of Spatial Frequency Response by Normal, Recovered Optic Neuritis, and Normal Fellow Eyes to a New Linearly Variable Neutral Density Device. Von Graefe's Arch 1993; 231:79-83.

75. Bielory L and Frohman LP. Allergic and Immunologic Disorders of the Eye. J Allergy Clin Immunol 1992; 861-15.

76. Mauriello J, Schulder M, Krieger A, DeLuca J, and Frohman, L. Management of Traumatic Optic Neuropathy-A Study of 23 Patients. Br J Ophthalmol 1992; 76:349-352..

77. Bielory L and Frohman, LP. Low Dose Cyclosporine A Therapy of Granulomatous Optic Neuropathy and Orbitopathy. Ophthalmol 98:1732-1736, 1991.

78. Frohman LP, Cook S, Bielory L. Dysgammaglobulinemia in Steroid Dependent Optic Neuritis. J Clin Neuro-ophthalmol 11:241-245, 1991.

79. Bielory, L, Noble, K, and Frohman, L. Urticarial vasculitis and visual loss. J Allergy Clin Immunology, 88:819-821,1991.

80. Frohman LP, Joshi VV, Wagner RS, Bielory L. Pseudotumor cerebri as a cardinal sign of the polyangiitis overlap syndrome. Neuro-ophthalmol 11:337-345,19912.

81. Bielory, LB, Cohen, A, and Frohman, LP. Migraines, spontaneous abortions, central nervous system involvement and a positive VDRL in a 36-year-old white female. Ann Allergy, 65:447-453, 1990.

82. Frohman, LP, Warren, F, and Kupersmith, MJK. The pituitary incidenteloma beyond the first year of follow-up. JAMA 264:2387,1990.

83. DeRespinis, R and Frohman, LP. Microwave Popcorn-Ocular Injury Caused by Steam. NEJM 323:1212,1990[6].

84. Bielory, LB, Conti, J, and Frohman, LP. Cogan's Syndrome. J Allergy Clin Immunology, 85: 808-815, 1990.

85. Bielory, L, Ogunkoya, O, and Frohman, LP. Temporal Arteritis in Blacks. Am J Med 86:707-708, 1989.

86. Wagner, RS and Frohman, LP. Long term results: Botulinum for sixth nerve palsy. J Ped Ophthalmol and Strabismus, 26:106-8, 1989.

87. Kupersmith, MJ, Burde, R, Warren, F, Klingele, TG, Frohman, LP, and Mitnick, H. Autoimmune Optic Neuropathy: Evaluation and Treatment. J Neurol Neurosurg and Psych 51:1381-86, 1988.

88. Bielory, L, Holland, C, Gascon, P, and Frohman, L. Uveitis, Cutaneous, and Neurosarcoid: Treatment with Low-Dose Cyclosporine A. Transplantation Proceedings: 20(3): June, 1988.

89. Kupersmith, M.J., Frohman, L.P., Choi, I.S., Foo, S.H., Hiesinger, E., Berenstein, A., Wise, A., Carr, R.E., and Ransohoff, J. Visual System Toxicity Following Intraarterial Chemotherapy. Neurology 38: 284-289,1988.

90. Frohman, Larry P., Pinto, Richard, Warren, Floyd, and Kupersmith, Mark J. Metrizamide Computed Tomographic Cisternography: A High-Yield Diagnostic Procedure for Chiasmal Syndromes with Equivocal Computed Tomographic or Magnetic Resonance Scans. Neuro-ophthalmol 7:251-266,1987[7].

91. Frohman, L.P., Klug, R., Bielory, L., Patti, J.C., and Noble, K. Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Unilateral Retinal Lesions and Bilateral Disc Edema. Am J Ophthalmol 104:548-550,1987.

92. Wagner, Rudolph S., Caputo, Anthony R., and Frohman, LP. Congenital Unilateral Adduction Deficit with Simultaneous Abduction: A Variant of Duane's Syndrome. Ophthalmol 94:1049-1053,1987.

93. Frohman, LP., Kupersmith, Mark, Lang, J.L., Bergeron, R.T., Reede, D.L., Aleksic, Slobodan, and Trasi, S. Pseudotumor of the Orbit with Bone Destruction and Intracranial Extension. Arch Ophthalmol 104:380-4, 1986.

94. Frohman, LP. and Kupersmith, Mark. J. Reversible Vertical Deviations Associated with Raised Intracranial Pressure. J Clin Neuro-ophthalmol 5:158-163, 1985.

95. Frohman, LP., Epstein, Fred, and Kupersmith, Mark. Atypical Visual Prognosis with an Optic Nerve Glioma. J Clin Neuro-ophthalmol 5:90-4, 1985.

Peer Reviewed Articles as Part of a Study Group – Frohman L, Clinical Trial Site Principal Investigator/Participant

1. Banik R; Kupersmith MJ; Wang JK; Garvin MK; NORDIC Idiopathic Intracranial Hypertension Study Group. The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients. Journal of Glaucoma. 28(4):352-356, 2019 Apr.

2. Kuehn MH; Mishra R; Deonovic BE; Miller KN; McCormack SE; Liu GT; Kupersmith MJ; Wall M; NORDIC IIHTT Study Group Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension. Journal of Neuro-Ophthalmology. 39(1):50-55, 2019 Mar.

3. Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE; NORDIC Idiopathic Intracranial Hypertension Study Group. The Relationship Between Optic Disc Volume, Area, and Frisen Score in Patients With Idiopathic Intracranial Hypertension. American Journal of Ophthalmology. 195:101-109, 2018 Nov.

4. Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, Wall M; and the NORDIC IIHTT Study Group Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial Headache. 2017 Sep;57(8):1195-1205. doi: 10.1111/head.13153. Epub 2017 Jul 28.

5. Wall M1, Kupersmith MJ2, Thurtell MJ3, Moss HE4, Moss EA2, Auinger P5; NORDIC Idiopathic Intracranial Hypertension Study Group. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12. Am J Ophthalmol. 2017 Apr;176:102-107. doi: 10.1016/j.ajo.2017.01.004. Epub 2017 Jan 17.

6. ten Hove MW1, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016 Mar;36(1):13-9. doi: 10.1097/WNO.0000000000000322.

7. Libien J1, Kupersmith MJ2, Blaner W3, McDermott MP4, Gao S4, Liu Y1, Corbett J5, Wall M6; NORDIC Idiopathic Intracranial Hypertension Study Group. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci. 2017 Jan 15;372:78-84. doi: 10.1016/j.jns.2016.11.014. Epub 2016 Nov 10.

8. Michael Wall, Matthew J Thurtell, for the NORDIC IIHTT Study Group, Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial  BJO Online First, published on January 27, 2017 as 10.1136/bjophthalmol-2016-309852

9. Weil R, Kovacs B, Miller N, McDermott MP, Wall M, Kupersmith M, Pi-Sunyer FX; NORDIC Idiopathic Intracranial Hypertension Study Group.A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension Obesity Science and Practice. 2016 Apr 5;2(2):95-103. doi: 10.1002/osp4.34. eCollection 2016 Jun

10. Cello KE1, Keltner JL, Johnson CA, Wall M; NORDIC Idiopathic Intracranial Hypertension Study Group. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016 Mar;36(1):6-12. doi: 10.1097/WNO.0000000000000327.

11. Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group.Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investigative Ophthalmology & Visual Science. 57(3):805-12, 2016 Mar.

12. Bruce BB, Digre KB, McDermott MP, Schron EB, Wall M; NORDIC Idiopathic Intracranial Hypertension Study Group.Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial. Neurology. 87(18):1871-1877, 2016 Nov 01.

13. Potical Coherence Tomography Substudy Committee; NORDIC Idiopathic Intracranial Hypertension Study Group. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology. 122(9):1939-45.e2, 2015 Sep.

14. Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M; NORDIC Idiopathic Intracranial Hypertension Study GroupQuality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results. Neurology. 84(24):2449-56, 2015 Jun 16.

15. Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE; NORDIC Idiopathic Intracranial Hypertension Study Group. Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results. Invest Ophthalmol Vis Sci. 2015 May 1;56(5):3292-303

16. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group The Idiopathic Intracranial Hypertension Treatment Trial Clinical Profile at Baseline JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.

17. Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ. The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuroophthalmol. 2014 Jun;34(2):107-17

18. Wall M, NORDIC Idiopathic Intracranial Hypertension Study Group. Effect of Acetazolamide on Visual Function in Patients with Idiopathic Intracranial Hypertension and Mild Visual Loss: The Idiopathic Intracranial Hypertension Treatment Trial. JAMA. 2014; 311(16):1641-51.

19. Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. Risk Factors for Poor Visual Outcome in Patients with Idiopathic Intracranial Hypertension. Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5.

20. John L. Keltner,1,2 Chris A. Johnson,3 Kimberly E. Cello,1 and Michael Wall4, for the NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline Visual Field Findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) Invest Ophthalmol Vis Sci. 2014 May; 55(5): 3200–3207.

B. Books, Monographs and Chapters

1. Frohman, L. Do Refractive Errors Cause Headaches? (Section VI – Question 31) In: Wagner RS (ed). Curbside Consultation in Pediatric Ophthalmology: 49 Clinical Questions. Thorofare, NJ, Slack Inc., 2014:155-7.

2. Frohman, LP. Scleroderma. In: Roy & Fraunfelder (eds), Current Ocular Therapy, 6th ed. Elsevier 2007.

3. Frohman L. Other Inflammatory Optic Neuropathies. In: Levin LA , Arnold AC (eds), Neuro-ophthalmology The Practical Guide. Thieme Publishers, New York, NY, 2005; pp 202-216.

4. Frohman L, Warren F. Skuta G (ed). PROVISION, ed 3., Neuro-ophthalmology Section. American Academy of Ophthalmology, 1998.

5. Frohman L, Lee A. The American Academy of Ophthalmology/North American Neuro-Ophthalmology Interactive Clinical Case Slide Atlas of Neuro-ophthalmology (CD-ROM), American Academy of Ophthalmology, 1998.

6. Frohman, L (ed). Provision Interactive (CD-ROM). Volume 2. American Academy of Ophthalmology, 1997.

7. Frohman L, Warren F, Wisnicki J, Johnson C, Rapuano C. Interactive Provision Interactive (CD-ROM). Volume 1 American Academy of Ophthalmology, San Francisco, 1996.

8. Frohman, L. Skuta G (ed). PROVISION, ed 2., Neuro-ophthalmology Section. American Academy of Ophthalmology, San Francisco, 1995

9. Frohman L, Bielory, L. Ocular and Neuro-ophthalmic Vasculitis. Advances in Clinical Ophthalmology, Volume 2, Burde RM , Slamovits TL ( eds). Mosby, St Louis, 1995.

10. Mauriello, J, Wagner, R, Mostafavi, R, Frohman, L. Oculinum therapy: Its Use in Neuro-Ophthalmology. In: Neuro-ophthalmological Disorders: Diagnosis and Treatment, Tusa R, Newman SA (Ed); Marcel Decker, 1994, 451-478.

11. Kupersmith M J, Weinberg H, Frohman LP, Warren F, Breinin GM. Ocular Myasthenia: Diagnosis and Treatment. In: Neuro-ophthalmology Enters the Nineties. Smith JL, Katz RS (eds). Dutton Press, Hialeah, FL, pp 173-182, 1988.

C. Patents Held

1. None

D. Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional Communications

a. Reviews

1. Frohman LP. Platform Review of “Pattern Visual Evoked Potential in the Diagnosis of Functional Visual Loss.” American Academy of Ophthalmology, Orlando, October, 1999.

2. Selected reviewer, American Academy of Ophthalmology, Preferred Physicians Response in Ophthalmology CME Series, Neuro-ophthalmology Section, 1992.

3. Frohman LP. Awarded reviewer. Clinical & Experimental Ophthalmology, 2015-2016.

b. Publications – Non Refereed Journals

1. Frohman L, Moore S, Burg S. How CD-ROM, Web Case studies offer interactive training. Tech Talk, Ophthalmology Times, March 1, 2000.

2. Frohman, LP. With Traumatic Optic Neuropathy, Surgery Not Always Right Option (letter) Ophthalmology Times, December 15, 1999.

3. Frohman LP. The Future of Interactive Ophthalmology Education, EyeNet Audio, in press.

4. Frohman, LP. Neuro-ophthalmic Manifestations of Vasculitis. Audio Digest-Ophthalmology 29:10, 1991.

E. Abstracts

1. Nanawati, N, Crane E, Modi K, Turbin RE, Frohman LP. Treatment of Secondary Pseudotumor Cerebri from Severe Anemia with Blood Transfusion . Invest. Ophthalmol. Vis. Sci.:ARVO , 2017.

2. Sheikh A, Langer PD, Mirani NM, Frohman LP, Prestigiacomo CJ, Turbin RE. Transcranial Orbitotomy after Superselective Coil Embolization Sacrifice of Intracranial Ophthalmic Artery Preserves Vision in Resection of Recurrent Large Orbital Apex Solitary Fibrous Tumor, Via Collateral Retrograde Orbital Circulation. (Poster) North American Neuro-ophthalmology Society, Tucson, AZ, February 28, 2016.

3. Korban A, Shulman S, Wong S, Frohman LP. Perioperative ischemic optic neuropathy after an orthopedic procedure. (Poster) Postgraduate Assembly in Anesthesiology, New York City, NY, December 1-15, 2015.

4. Huz J, Frohman L, Turbin RE, Bhagat N. Optic Neuropathy Following Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detatchment. Invest. Ophthalmol. Vis. Sci. 2015;56 :ARVO E-Abstract 5094.

5. Elenein RGA, Frohman LP, Turbin RE. Analysis of Therapeutic Agents and Their Effectiveness in Sarcoid Optic Neuropathy. [Poster 99]. 38th Annual North American Neuro-Ophthalmology Society Meeting Program Planner, San Antonio, TX, February 14, 2012.

6. Baumrind BR, Shah VP, Frohman L, Turbin R. Occult neurosarcoid can mimic idiopathic intracranial hypertension (IIH). Invest Ophthalmol Vis Sci 2011; 52:E-Abstract 3885.

7. Elenein RGA, Frohman LP, Turbin RE. Visual Outcome of Unaffected Eye in Idiopathic Intracranial Hypertension with Unilateral Papilledema. [Poster 98]. 37th Annual North American Neuro-Ophthalmology Society Meeting Program Planner, Vancouver, Canada, February 8, 2011.

8. Pham M, Frohman LP, Turbin RE. Does Lacrimal Gland Size on MRI Scans Differentiate Sarcoid from Demyelinating Optic Neuritis. [Poster 82]. 37th Annual North American Neuro-Ophthalmology Society Meeting Program Planner, Vancouver, Canada, February 8, 2011.

9. Kim HJ, Chu D, Frohman LP, Turbin RE. Correlation of histologic changes in lacrimal and salivary glands to gallium and MRI findings in sarcoid suspects. International Ocular Inflammation Society Congress, Prague, Czech Republic. May 29 –June 3, 2009.

10. Kim HJ, Levin F, Turbin RE, Wolansky L, Bielory L, Frohman LP. Location of radiographic optic nerve involvement as a predictor of visual outcome in sarcoid optic neuropathy. [poster] Invest Ophthalmol Vis Sci 2008; 49:E-Abstract 6017. [abstract] Invest Ophthalmol Vis Sci 2009; 50:E-Abstract 4033.

11. Ebrahim BY, Frohman L, Bhagat N. Tonic pupil following pars plana vitrectomy and endolaser. [poster] Invest Ophthalmol Vis Sci 2008; 49: E-Abstract 5233.

12. Shinder R, Szirth BC, He W, Frohman LP, Turbin RE. Amplitude latency and constriction/ dilation velocity of an afferent pupillary defect as measured with a pupillometer. [poster] Invest Ophthalmol Vis Sci 2007; 48: E-Abstract 5538.

13. Tannen B, Chu D, Langer P, Cheongeun O, Ghesani N, Zuckier L, Frohman L, Turbin R. Correlation of Lacrimal Gland Uptake Using Gallium Scan with Lacrimal Biopsy Results in Sarcoidosis Suspects. [Poster #90] 33rd Annual North American Neuro-Ophthalmology Society Meeting Program Planner, Snowbird, UT, February 11-15, 2007; p 218.

14. Shah R, Szirth B, Grant G, Bennet H, Heary R, Fechtner R, Frohman L, Turbin R. Pupillometry is Feasible Despite Intravenous Remifentanil Induced Miosis During Prone Spinal Surgery (PSS) Using Modified Proneview(tm) Helmet and Jackson Spinal Table. [Poster #67] 33rd Annual North American Neuro-Ophthalmology Society Meeting Program Planner, Snowbird, UT, February 11-15, 2007; p 195.

15. Lombardo N, Frohman L, Digre K. Building an Academic Library-Professional Society Partnership: The Neuro-ophthalmology Virtual Education Library. (Poster #35) 33rd Annual North American Neuro-Ophthalmology Society Meeting Program Planner, Snowbird, UT, February 11-15, 2007; p 163.

16. Shahid K, Forofonova T, Frohman L, Turbin R, Szirth B. Determining Preferred Fixation Pattern Using Eye Tracking Microperimetry in Nystagmus. Annual Meeting Abstract accessed at . org /conf /2006 /posters.htm. The American Telemedicine Association 11th Annual Meeting, San Diego, CA, May 2006. Poster #72.

17. Turbin RE, Choice CV, Bennett HL, Heary R, Szirth BC, Tutela AC, Tannen BL, Khouri A, Frohman LP, Xiong M, Fechtner RD. Use of the Proneview TM Helmet System with a Modified Table Platform for Open Access to the Eyes during Prone Spinal Surgery. (Poster #29) 32nd Annual North American Neuro-Ophthalmology Society (NANOS) Meeting Program Planner and Abstract Book, 2006; p209.

18. Wladis EJ, Mirani N, Frohman LP, Langer PD, Turbin RE. The Clinical and Radiographic Spectrum of Post-Operative Optic Nerve Sheath Fenestration Pseudomeningoceles (poster). Investigative Ophthalmology and Visual Science 2005; 46:E-Abstract 652.

19. Pruzon J, Hood D, Roy MS, Chutorian A, Turbin RE, Frohman LP. Electroretinographic Abnormalities in a case of Rosenberg-Chutorian Syndrome. (Poster #59) 31st Annual North American Neuro-Ophthalmology Society (NANOS) Meeting Program Planner and Abstract Book, 2005; p244.

20. Turbin RE, Nilay S, Cadavid D, Wolansky LJ, Liu J, Joseph G, Haghighi M, Skurnick J., Frohman LP, Cook SD. Contemporary Imaging of Multiple Sclerosis using Triple-dose and 3.0 T: Preliminary data from the "BECOME" study. 31st Annual North American Neuro-Ophthalmology Society (NANOS) Meeting Program Planner and Abstract Book, 2005; p168

21. Turbin RE, Frohman LP, Farkas J, Mirani N, Cuadra S, and Padberg F. When All Else Fails, Lay on Hands. In: CD-ROM: 37th Annual Frank B. Walsh Session. 31st Annual Meeting North American Neuro-ophthalmology Society. Copper Mountain, CO, February 13, 2005.

22. Gollance SA, Frohman LP, Grigorian RA, Turbin RE, Roy MS, Bielory LJ. Is Raynaud’s Phenomenon a Risk Factor for Non-Arteritic Ischemic Optic Neuropathy? (abstract). 2004 Annual Meeting Abstract and Program Planner accessed at Association for Research in Vision and Ophthalmology. Abstract 1590.

23. Turbin RE. Wladis EJ, Frohman LP. Total Blindness as the Presenting Sign of Small Cell Lung Cancer. (abstract). 2004 Annual Meeting Abstract and Program Planner accessed at

24. .org Association for Research in Vision and Ophthalmology. Abstract 1614.

25. Frieman BJ, Frohman LP, Turbin RE. Traumatic Optic Neuropathy: A Review of 32 Cases. (abstract). 2004 Annual Meeting Abstract and Program Planner accessed at Association for Research in Vision and Ophthalmology. Abstract 1606.

26. Turbin RE, Wladis EJ, Frohman LP. Total Blindness as the Presenting Sign of Small Cell Lung Cancer. Investigative Ophthalmology and Visual Science 2004; 45:E-Abstract 1614

27.

28. of the Need for Radiation Therapy in Sclerosing Orbital Pseudotumor. Investigative Ophthalmology and Visual Science 2004; 45:E-Abstract 269.

29. Maxwell DN, Turbin RE, Frohman L, Langer P. A review of low-velocity transorbital intracranial injury-occult versus non-occult patterns of penetration (#76) 30th Annual North American Neuro-Ophthalmology Society (NANOS) Meeting Program Planner and Abstract Book, 2004; p288.

30. Wladis EJ, Turbin RE, Langer PD, Frohman LP, Kennerdell JS. Salvage Therapy for Optic Nerve Sheath Meningioma. (#66) 2003 American Academy of Ophthalmology Meeting Program Planner and Abstract Book, 2003; p138.

31. Turbin RE, Prasad A, Marmor MA, Kodis S, Frohman L, Sharer L, Carmel P, Wolanski L, Epiphora torticollis, and photophobia–Triad symptoms and neuroanatomic correlates in the lateral medulla. PO218, 2003 American Academy of Ophthalmology Meeting Program Planner accessed at program03. cfm.

32. Turbin RE, Langer P, Frohman L. The superior-medial lid crease orbitotomy: A Photoessay and Video. 35th Frank B. Walsh Annual Session of the 29th Annual North American Neuro-Ophthalmology Society (NANOS) Meeting Program Planner and Abstract Book, 2003; p130.

33. Turbin R, Frohman L, Carmel P, Prasad A, Sharer L, Wolansky L. Case 5: Can You Remember Another Triad. In: CD-ROM: 35th Frank B. Walsh Annual Session of the 29th Annual North American Neuro-Ophthalmology Society (NANOS). Snowbird, Utah February 9, 2003.

34. Yamani A, Turbin RE, Langer PD, Frohman L. Frequency of Developing Generalized Myasthenia Gravis in Patients With Combined Ocular Myasthenia and Graves Disease (abstract). 2002 Annual Meeting Abstract and Program Planner accessed at Association for Research in Vision and Ophthalmology. Abstract 2643.

35. Turbin RE , Khoobiar SA, Langer P, Amesur K, Frohman L, Warren F, Baredes S, Kennerdell JS. Adjuvant Therapy for Invasive Sino-orbital Fungal Infection (abstract). 2002 Annual Meeting Abstract and Program Planner accessed at Association for Research in Vision and Ophthalmology. Abstract 2637.

36. Frohman LP, D’Amato PR. Management of Traumatic Optic Neuropathy in the Comatose/Confused Patient (abstract). 2002 Annual Meeting Abstract and Program Planner accessed at Association for Research in Vision and Ophthalmology. Abstract 2635.

37. Turbin RE, Frohman LP, Facciani J, Carmel P, Lee HJ, Wolansky L, Chu L. Rare, That's an Understatement. CD-ROM: 34th Frank B. Walsh Annual Session of the 28th Annual North American Neuro-Ophthalmology Society (NANOS). Copper Mountain, CO, February 16, 2002.

38. Frohman L, Turbin R, Bielory L, Cook S. She’s Only 8, Should She See the ABC’S. CD-ROM: 33rd Frank B. Walsh Annual Meeting of the 27th Annual North American Neuro-Ophthalmology Society (NANOS). Rancho Mirage, CA, February 18, 2001.

39. Balayan G, Guirgis M, Frohman L, Bielory L. Ocular Manifestations of Sarcoidosis: An Immunological Disorder. Annals of Allergy 1999;82(1):129.

40. Kupersmith MJ, Frohman LP, Sanderson MC, Jacobs J, Warren FA, Chu C, Hirschfeld J. Aspirin Reduces Second Eye Anterior Ischemic Optic Neuropathy (AION). Ophthalmol 1995;102(supp 9A):104.

41. Narain K, Frohman L. Clinical Findings in Traumatic Chiasmal Injury. Invest Ophthalmol Vis Sci (Suppl) 6:681;1995.

42. Bhuiyan S, Kupersmith M, Frohman L, Volpe N, Warren F, Repke K. Visual Outcome of Treated Sarcoid Optic Neuropathy Inv. Ophthalmol. 36:680;1995.

43. Sanderson M, Kupersmith M, Frohman L, Jacobs L, Hirschfield J, Ku C, Warren F. Aspirin Reduces Anterior Ischemic Optic Neuropathy (AION) in the Second Eye. Inv. Ophthalmol. 36:196;1995.

44. Bielory, L, Wilkerson, M, Frohman, L, Constad W. Tear fluid IgG in AIDS. J Allergy Clin Immunol. 89:729a, 1992..

45. Anagnoste, S, Frohman, L, and Bielory, L. Electrophoretic Pattern of Fresh versus Frozen Human Optic Nerve. Invest Ophthalmol Vis Sci (suppl) 33:1226, 1992.

46. Rescigno, R, Frohman, L, and Bielory, L. Immunoglobulin Content of Aqueous Humor. Invest Ophthalmol Vis Sci (suppl) 33:849, 1992.

47. Haupt, EJ, Frohman, L, Katz, R, Chin, P, Cinotti, AA. Differential Diagnosis of Fellow and Recovered Neuritis Eyes with a New Linearly Variable Neutral Density Filter. Invest Ophthalmol Vis Sci (suppl) 32:949, 1991.

48. Amornmarn L, Frohman, L, Wolff, A, Bielory, L. Relapsing polychondritis Treatment with Cyclosporine. Ann Allergy 66:90a., 1991.

49. Frohman, L, Bielory, L, Warren, F, Bystryn, J, and Kupersmith,M. Skin Biopsies in the Evaluation of Atypical Optic Neuropathies. Investigative Ophthalmol Vis Sci (suppl) 32:951, 1991.

50. Lieberman, F, Frohman, L, Bielory, L, Keltner, J, and Thirkill, C. Paraneoplastic optic neuropathy and Anti-Car Antibody. Neurology (suppl 1) 40:280, 1990.

51. Bielory L, Shah H, Cohen A, and Frohman, L. Localization of Phospholipid-Zones in Human Optic Nerve. Investigative Ophthalmology and Visual Science 31(4):39, 1990.

52. Frohman L, Rescigno R, Holland C, and Bielory L. Visual Manifestations of the Antiphospholipid Antibody Syndrome. Ophthalmology, (suppl) 96:105,1989.

53. Bielory, L, Dong, Z, Yip, P, and Frohman, L. Anticardiolipin Antibody Binding to Human Optic Nerve. Clinical Research 37:855a, 1989.

54. Wagner, Rudolph S., Frohman, Larry P., and Litecky, Raymond J. Prevention of Secondary Contracture of the Medial Rectus Muscle by Botulinum Toxin Chemo-denervation in Sixth Nerve Palsies. Invest Ophthalmol Vis Sci (suppl) 28:34,1987.

55. Wagner, Rudolph S., Frohman, Larry P., and Caputo, Anthony. Congenital Adduction Palsy and Synergistic Divergence: A Variant of Duane's Syndrome. Ophthalmology 93(suppl):123, 1986.

56. Frohman, Larry P., Pinto, Richard, Warren, Floyd, and Kupersmith, Mark J. Metrizamide Computed Tomographic Cisternography: Procedure of Choice for Chiasmal Syndromes with Equivocal CT Scans. Ophthalmology 93(suppl):69,1986.

57. Kupersmith, Mark, Frohman, Larry, Warren, Floyd, and Pinto, Richard. Diagnosis andTreatment of Unusual Disorders of the Chiasm. Annals of Neurology 20:140, 1986.

58. Kupersmith, Mark J., Weinberg, Harold, Frohman, Larry, Warren Floyd, and Breinin, Goodwin M. Ocular Myasthenia: Diagnosis and Treatment. Annals of Neurology 18:159, 1985.

59. Kupersmith, Mark J., Frohman, Larry P., Kleinberg, David, Budzolovich, Gleb, Cooper, Paul, and Ransohoff, Joseph. Escape from Bromocriptine. Annals of Neurology 18:142, 1985.

60. Kupersmith, Mark J., Frohman, L.P., Carr, R.E., Wise, A. Foo, S.H., Ransohoff, J., and Choi, I.S. Visual Dysfunction Related to Intraarterial Chemotherapy for Gliomas. Neurology 35(suppl 1):114, 1985.

F. Reports

1. Ebrahim B, Frohman LP, Zarbin MA, Bhagat N. Tonic pupil following pars plana vitrectomy and endolaser. Case Reports in Medicine accessed at journals/crm/ 2009/970502.html, Volume 2009 (2009), Article ID 970502, 3 pages.

-----------------------

[1] Youngest ophthalmologist listed in US

[2] Since I became Executive Vice President of NANOS (2011-) I participate in the business of and discussions of all NANOS Committees (currently, n=38).

[3]Clinical Challenges in Survey of Ophthalmology does not get indexed under the name of the physician who writes the discussion.

[4]Clinical Challenges in Survey of Ophthalmology does not get indexed under the name of the physician who writes the discussion.

[5]This article was placed in the initial volume of this journal; first year does not appear in Index Medicus.

[6]This letter does not appear in Index Medicus

[7]This European journal was not at that time in Index Medicus

Download Doc File